EYAL MUSCAL to Immunoglobulins, Intravenous
This is a "connection" page, showing publications EYAL MUSCAL has written about Immunoglobulins, Intravenous.
Connection Strength
0.712
-
Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey. J Neurol. 2017 Apr; 264(4):647-653.
Score: 0.519
-
Parent perceptions of various treatment approaches for PANS and PANDAS. J Affect Disord. 2025 Jan 15; 369:1215-1222.
Score: 0.055
-
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children. Arthritis Rheumatol. 2023 08; 75(8):1466-1476.
Score: 0.050
-
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis. JAMA Neurol. 2021 11 01; 78(11):1333-1344.
Score: 0.045
-
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults. JAMA Netw Open. 2021 02 01; 4(2):e2036321.
Score: 0.043